Penumbra Q3 2021 Earnings Report
Key Takeaways
Penumbra, Inc. reported financial results for the third quarter ended September 30, 2021, with revenue reaching $190.1 million, a 25.8% increase compared to the third quarter of 2020. The company is increasing its guidance for 2021 total revenue to be in the range of $735 million to $740 million.
Total revenue increased to $190.1 million, a 25.8% increase compared to Q3 2020.
Revenue from vascular products grew by 40.3% to $105.5 million.
Revenue from neuro products grew by 11.5% to $84.7 million.
The company is increasing its guidance for 2021 total revenue to be in the range of $735 million to $740 million, which represents 31% to 32% growth over 2020 revenue.
Penumbra
Penumbra
Penumbra Revenue by Geographic Location
Forward Guidance
The Company is increasing its guidance for 2021 total revenue to be in the range of $735 million to $740 million, which represents 31% to 32% growth over 2020 revenue of $560.4 million.
Revenue & Expenses
Visualization of income flow from segment revenue to net income